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Abstract
Coronary embolic phenomena (CEP) are difficult to diagnose yet carry poten-
tially devastating clinical consequences. The goal of this chapter is to outline key 
processes and pathophysiologic mechanisms underlying CEP, primarily in the 
context of acute coronary syndrome (ACS). Not surprisingly, most reported cases 
of CEP occur in the left coronary circulation, but some right-sided events have been 
reported. Overall, causes include thrombotic, septic/infectious, neoplastic, valve-
related, and iatrogenic mechanisms such as air embolization. Coronary angiography 
remains the definitive diagnostic and therapeutic approach, with computed tomog-
raphy being increasingly utilized. Transthoracic echocardiography (TTE) should be 
part of a routine work up for patients with suspected CEP. Holter/event monitoring 
for atrial fibrillation may also be indicated in patients with embolic phenomena. 
Clinical management includes procedural restoration of coronary blood flow, 
followed by appropriate anticoagulation or antiplatelet therapy, in conjunction with 
appropriate treatment of any arrhythmias or other associated cardiac manifesta-
tions or conditions. Timely diagnosis, based on a high index of suspicion (especially 
in high-risk population) may be important in improving morbidity and mortality in 
affected patients. Since CEPs are often underdiagnosed and may be due to a number 
of heterogeneous causes, the need arises for increasing provider awareness of these 
important phenomena, as well as for the implementation of appropriate clinical 
management guidelines.
Keywords: coronary artery embolism, coronary embolic phenomena, diagnosis, 
management, risk factors
1. Introduction
Coronary embolic phenomena (CEP) constitute an under-reported and underdi-
agnosed set of clinical phenomena, with potentially devastating consequences if not 
recognized and treated promptly [1–3]. From coronary air embolism to paradoxical 
venous thromboembolism, CEPs represent an etiologically heterogeneous group of 
events [4–7]. It has been postulated that CEPs are the underlying cause of up to 3% 
of acute coronary syndromes (ACS) [6]. Given their rarity, CEPs require a high index 
of suspicion by the treating clinician [8–10]. In this chapter, we will aim to cover 
the various processes and pathophysiology underlying this cause of acute coronary 
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syndrome. Our focus will be on the more commonly seen forms of coronary embo-
lism, with an abbreviated overview provided of the less common etiologies.
2. Methods
A thorough literature search was conducted using PubMed, Google™ Scholar, 
and Bioline International. The following search terms were utilized, in various 
combinations/derivations/iterations, listed alphabetically: “cardiac,” “coronary,” 
“emboli,” “embolism,” “embolus,” “heart,” “infarction,” “myocardial,” “myocar-
dium,” “paradoxical,” “phenomenon,” “vascular,” “vasculature,” and “vessel”. 
Secondary identification of additional literature sources was performed using 
articles referenced by our primary sources.
3. Classification
Coronary emboli may be classified based on etiology (i.e., thrombotic, septic, neo-
plastic, valvular heart disease-related, iatrogenic), although other classifications (i.e., 
direct, paradoxical and/or iatrogenic) have been proposed and/or described [6, 11–13]. 
A list of all previously reported types/causes of coronary emboli is provided in Table 1.
4. Mechanisms and pathophysiology
Coronary emboli may originate in the left or right side of the heart [14, 15]. 
Of course, for emboli originating in the right heart to lodge in the coronary arter-
ies, they would need to be somehow “shunted” to the left-sided system, possibly 
Thrombotic Paradoxical thrombus/embolus
Left atrial appendage thrombus
Left atrial thrombus
Left ventricular mural thrombus
Autoimmune Inherited coagulation factor deficiencies (prothrombin deficiency, protein C/S 
deficiency)
System lupus erythematosus
Antiphospholipid syndrome
Infectious Infective endocarditis
Rheumatic heart disease
Valve-related Fibroelastoma
Mitral valve calcifications
Blood cysts
Neoplastic Malignancy
Iatrogenic Post-cardiac procedure
Miscellaneous causes Pregnancy
Air embolism
Table 1. 
Causes of coronary embolism.
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through a patent foramen ovale [16–18]. An angiographic example of paradoxical 
coronary artery embolism is show in Figure 1 [19].
It must be mentioned here that systemic emboli finding their way to the left heart 
are still more likely to embolize to the carotid or intracranial vasculature, primarily 
due to two particular considerations. Firstly, the coronary anatomy and coronary 
artery takeoff is typically such that emboli are less likely to specifically dislodge and 
enter into their ostia [13, 20, 21]. Secondly, it is hypothesized that coronary vessels 
may be protected to some degree, mainly due to them receiving flow primarily during 
diastole [22–26]. For similar reasons, one might extrapolate that most reported cases 
of coronary embolism occur in the left coronary circulation due to the anatomy of the 
right coronary artery takeoff making it potentially less conducive to emboli [22–28].
Coronary emboli may become lodged in major epicardial arteries supplying a siz-
able area of myocardium, and smaller emboli may even embolize distally so as to affect 
small arterioles which do not supply a large area [29–31]. These events may or may not 
be clinically symptomatic or readily diagnosable, but evidence in this generally poorly 
understood area of cardiac pathophysiology continues to be lacking. It is important to 
note, however, that coronary emboli may occur in the setting of concomitant athero-
sclerosis, where even a small embolus could lodge at the site of atherosclerotic lesion 
and result in significant epicardial coronary occlusion, thus exposing potentially sig-
nificant area of myocardium at risk for a subsequent secondary ischemic event [31–35]. 
An association with infectious etiology may be present as well in this context [32].
5. Coronary embolic events: a heterogeneous pathologic grouping
Due to various mechanisms being responsible for coronary embolic phenom-
ena leading to acute coronary syndromes, we will address them one by one in the 
Figure 1. 
Angiographic example of a large coronary artery embolus located in the mid-left anterior descending artery. 
Source: Zhang et al. [19]. Image used under the terms of the Creative Commons Attribution 4.0 License (http://
www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work 
without further permission provided the original work is attributed as specified on the SAGE and Open Access 
pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
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subsequent discussion. The authors’ goal is not to provide an exhaustive description 
of each mechanism, but rather to point the reader to other definitive sources for 
further details.
5.1 Thrombotic causes
Coronary emboli may be formed due to thromboembolic causes involving dif-
ferent etiologies and pathways (Table 1). As with all thromboembolic phenomena, 
predisposing conditions of the Virchow’s triad (hypercoagulability, stasis, endothe-
lial injury) will need to be present for thrombi to form [36, 37].
For venous thromboemboli to “transform” into coronary emboli, the presence 
of a patent foramen ovale is required [6, 38]. This enables the embolus to cross 
from “right to left” side of the heart and thus develop the potential to lodge in the 
coronary circulation [18, 38]. A thrombus may originate in the left atrial append-
age, as seen among patients with atrial fibrillation [39, 40], or it may originate in 
the left atrium/ventricle itself, as in patients with severely reduced ejection fraction 
or those who have had an anterior/apical myocardial infarction in the past [6, 41]. 
The former is of particular clinical importance, as patients diagnosed with coronary 
embolus may benefit from ambulatory monitoring to look for atrial fibrillation as a 
possible underlying cause.
Arterial emboli are more likely to be reported in the setting of hypercoagulable 
states including autoimmune diseases, inherited coagulation factor deficiencies, 
hyperviscosity syndromes, and acquired hypercoagulabe states (e.g., pregnancy, 
malignancy, previous heparin exposure, Table 1) [42–44]. As coronary emboli are 
a rarely reported phenomenon, no randomized trials or guidelines exist regarding 
diagnostic workup for these, although it would not be unreasonable to initiate workup 
for thrombophilia whenever appropriate diagnosis or suspicion exists [37, 42–45].
5.2 Septic/infectious causes
Infective endocarditis is one of the most dreaded infectious etiologies associated 
with significant morbidity and mortality [46, 47]. Coronary septic arterial emboli 
(CSAE) secondary to infectious endocarditis have been reported and according to 
one source such events may carry a mortality of up to 50% [48]. CSAE appear to 
be more likely to occur in patients having vegetations of the mitral valve or fungal 
infections, as fungal vegetations are known to reach larger overall dimensions, thus 
increasing the cumulative possibility of embolization [49, 50]. Rheumatic heart 
disease, though more common in low-income countries, is another possible etiol-
ogy that can be associated with CSAE and must be kept in mind when evaluating 
patients from high-incidence geographic areas [51, 52].
5.3 Neoplastic causes
Tumors originating in the heart such as atrial myxomas, or on valves such as 
papillary fibroelastomas, are well known to cause cryptogenic brain infarctions 
[14, 53]. There are also reports of embolization to the coronary circulation [54–56]. 
Given that end-organ damage, including cerebrovascular accidents may constitute 
the initial clinical presentation of such neoplasms, it would not be unreasonable to 
propose that an embolic myocardial infarction may occur in this setting [56, 57]. It is 
also likely that such occurrences are under-recognized and probably more common 
than generally thought, thus requiring high index of clinical suspicion and prompt 
diagnosis [56, 57]. The overall urgency is highlighted by the possibility that subse-
quent presentations in cases of “missed diagnosis” may manifest as unexplained/
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sudden death [57, 58]. Appropriate high-quality imaging may include but is not 
limited to transthoracic and/or transesophageal echocardiography [56, 59–61].
5.4 Valve-related causes
Stenotic heart valves resulting from progressive calcification process also pose 
the possibility of calcific embolization to distal locations, including the coronary 
circulation [48, 62, 63]. Rheumatic valvular heart disease could be another possible 
risk factor for coronary embolization [48]. Long-term valvular heart disease leads 
to structural changes in the myocardium, eventually increasing the risk of atrial 
fibrillation, which in itself may be a contributor to both systemic and coronary 
embolization [39, 64]. Of note, coronary embolism has been reported following aor-
tic and mitral valve replacement, with successful management reported to involve 
abciximab and urokinase [65]. Another report describes acute myocardial infarction 
due to coronary embolism in a patient with mitral valve prosthesis. That particular 
case was successfully managed using angioplasty [66]. An example of a left coro-
nary embolism associated with subtherapeutic oral anticoagulation in a patient with 
mitral and aortic mechanical valve prostheses is shown in Figure 2 [67].
5.5 Iatrogenic causes
Ruptured atherosclerotic plaques in the coronary arteries may lead to acute 
thrombotic occlusions and are the frequent pathophysiologic factor behind acute 
ST-elevation myocardial infarctions [68, 69]. Vessels affected by such processes 
may be characterized by a high thrombotic burden. For example, saphenous venous 
grafts in post-coronary artery bypass graft patients seem particularly vulnerable 
[70, 71], with various pathophysiologic mechanisms proposed including immune-
mediated process [71, 72].
Cardiac catheterization procedures may also cause distal embolization of intra-
vascular particles [73]. Depending upon where, and how far, any dislodged thrombi 
or microthrombi travel, periprocedural myocardial infarction can become a very 
real risk [74]. Various procedural techniques including specialized “wire filter” 
protection devices [74, 75] and thrombus extraction catheters [76] can be utilized 
during coronary interventions to prevent or reduce distal embolization. Finally, 
Figure 2. 
An example of a left coronary artery coronary embolism associated with subtherapeutic anticoagulation in the 
setting of mitral and aortic mechanical valve prostheses. [A, left] Note the filling defect present upon initial 
diagnosis. [B, right] Following thrombectomy, the left coronary artery is seen to be patent. Source: Protasiewicz 
et al. [67]. Images used under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported 
License, which permits all noncommercial use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
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distal coronary embolization involving cholesterol particles is also a possibility in 
patients undergoing diagnostic coronary angiography or thrombolysis [77, 78].
6. Diagnosis of coronary embolism
A careful history and physical examination is necessary, with specific focus on 
finding any systemic signs of emboli in septic patients, as well as the possibility 
of an autoimmune disease in the subset of non-septic patients [79–81]. As with 
suspected coronary artery disease, patients suffering from coronary embolism 
may present with typical or atypical chest pain or with “angina equivalents” such 
as dyspnea [79, 81, 82]. As with all acute coronary syndromes, electrocardiography 
will be very important in determining the diagnosis and may dictate the urgency for 
cardiac catheterization (e.g., the presence of ST-elevation myocardial infarction). 
The presence of Q-waves in contiguous leads may be indicative of a “silent” myo-
cardial infarction. Troponin and other cardiac enzyme testing certainly plays an 
important role in determining the extent and the progression of myocardial isch-
emia [83, 84]. Subsequent workup should include transthoracic and transesopha-
geal echocardiography, advanced high-resolution imaging (e.g., CT or MRI), and 
coronary angiography [18, 85–87]. In addition, miscellaneous adjunctive diagnostic 
tools, such as Holter/event monitoring, can also be helpful in cases where etiology 
of the event(s) in question may be uncertain [88, 89].
6.1 Coronary angiography
Coronary angiography remains the mainstay of CEP diagnostics [87]. As out-
lined previously, patients affected by this condition may have “silent” myocardial 
infarction or may present with an acute ST segment elevation myocardial infarc-
tion. When performing angiography, associated thrombi have a distinct hazy 
angiographic appearance [87, 90, 91]. Moreover, angiography can help document 
the evolution and resolution of coronary embolism [92]. Finally, diagnostic 
angiography can be converted into a therapeutic procedure if indicated [87, 93].
The angiographer should keep in mind that the presence of multiple acute 
thromboembolic lesions in various vessels increases the suspicion for embolic 
coronary phenomena [94]. As mentioned above, these emboli may also acutely 
occlude parts of vessels with pre-existing atherosclerosis, further complicating the 
diagnosis. Intravascular ultrasound following aspiration atherectomy may be useful 
when assessing for underlying atherosclerosis versus purely acute thromboembolic 
phenomena. Optical coherence tomography of these vessels may also be useful but 
has not yet been studied sufficiently in this particular setting [95, 96]. A patient with 
angiographic evidence of coronary embolism but with no traditional risk factors 
for coronary artery disease should raise the suspicion for some of the less common 
causes (e.g., autoimmune, infectious, inflammatory, or neoplastic) [6, 94, 97].
After diagnostic confirmation, coronary thrombi are often removed using 
aspiration catheters, as outlined in previous paragraphs. Biopsy of these specimens 
would aid in differentiating between thrombotic, septic, and neoplastic causes of 
embolism, particularly due to the fact that these may be the presenting events in 
some neoplasms. Autoimmune disease may also need to be ruled out [6, 94, 97].
6.2 Transthoracic echocardiography
Transthoracic echocardiography should be a part of the routine workup for 
patients with suspected CEP. Diagnostically, it will be critically important to 
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demonstrate or rule out the presence of patent foramen ovale [98–100] and identify 
any thrombi in left-sided cardiac chambers, particularly with the help of ultrasonic 
contrast [33, 59]. Any suspicion should be further supplemented with transesopha-
geal echocardiography to ascertain any transthoracic echocardiography findings, 
especially those of uncertain significance or insufficiently granular detail(s) [59, 101]. 
In addition, this would also be helpful to visualize the left atrial appendage when 
looking for evidence of either stasis or thrombus formation there [102, 103]. Such 
findings can be present in the setting of atrial fibrillation [102].
As outlined earlier in this manuscript, Holter/event monitoring to look for atrial 
fibrillation would also be reasonable in patients being seen for embolic phenomena 
[88, 89]. As for all thromboembolic diseases, thrombophilia workup would also be 
useful in ascertaining the etiology of coronary embolism in appropriately selected 
at-risk patients [104].
7. Clinical management
Coronary embolic syndromes are quite heterogeneous, and lack random-
ized controlled trial data or specific guidelines on their management. The initial 
approach including timing of cardiac catheterization for coronary embolism should 
be the same as for routine acute coronary syndrome (with classification of available 
evidence quality provided in parentheses) [106].
Oxygen (Class 1), nitrates (Class 1), and beta blockers (Class 1) are the mainstay 
of the initial medical management [106] in addition to parenteral anticoagulation 
(Enoxaparin/unfractionated heparin [UHF]/Bivalirudin) [109].
Decision regarding the use of percutaneous coronary intervention versus bal-
loon angioplasty would be up to the clinician’s judgment given plaque morphology 
as assessed by intravascular ultrasound as well as on optical coherence tomography.
Following the initial management, dual antiplatelet inhibition would be 
recommended for these patients [107] for a duration of 6–12 months as per the 
2017 American College of Cardiology (ACC)/American Heart Association (AHA) 
Guidelines [108].
As no randomized controlled data are available on lipid management for the 
particular subset of patients suffering from coronary embolism, we would recom-
mend following current society guidelines for lipid management in these patients.
For patients with reduced ejection fraction on echocardiography, angiotensin 
converting enzyme (ACE) inhibitors or angiotensin receptor blockers in addition to 
aldosterone antagonists are recommended (Class 1) [106, 109].
Long-term anticoagulation in patients diagnosed with embolic coronary disease 
remains a question to be answered. As with other embolic phenomena, 3–6 months 
of anticoagulation with warfarin or with direct anticoagulants would be reasonable, 
with further therapy to be decided upon ascertaining the underlying etiology.
Workup to determine the etiology is essential, and treatment of the cause of 
embolism is of course necessary. As mentioned above, remote cardiac monitoring to 
look for atrial fibrillation is essential as it may necessitate lifelong anticoagulation 
particularly in patients with high CHADS2VASC scores.
Lastly, in patients possibly requiring triple antithrombotic therapy, data are 
limited, with current management approaches based on consensus recommenda-
tions with only a brief mention in the 2016 ACC Guidelines [108]. The decision 
regarding the duration or discontinuation of triple therapy versus P2Y12 inhibitor 
plus vitamin K antagonists (VKA)/direct oral anticoagulants (DOAC) would be 
based on the individualized bleeding risk versus the potential risk of discontinuing 
these medicines [108].
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8. Miscellaneous causes
It has been reported that air embolism can complicate a variety of invasive 
procedures involving the vasculature, from central venous access placement to 
coronary artery bypass grafting [105, 106]. In the context of CEPs, the presence of 
patent foramen ovale (PFO) plays an important contributory role [107]. Though 
rarely reported, air embolism due to decompression illnesses or due to iatrogenic 
causes may also cause coronary embolism. Finally, iatrogenic CEPs are fortunately 
uncommon, yet they are dreaded events that may occur in the cardiac catheteriza-
tion lab or during coronary artery bypass graft (CABG) surgery [103, 104].
Amniotic fluid embolism (AFE) in pregnant women can also lead to coronary 
embolization [105, 108]. Of note, for amniotic fluid to embolize to the coronary 
arteries, the patient must also have a PFO which helps facilitate the right-to-left 
transit of causative particles, which then lodge in the systemic arterial system and, 
potentially, the coronary arteries. It has been noted that the appearance of amniotic 
fluid emboli in the coronary circulation may be associated with elevated mortal-
ity when compared with cases not involving the coronary vessels [108]. Marked 
constriction of coronary arteries has also been described in the setting of AFE, 
although it is not known if that is a direct or an indirect effect [109, 110].
9. Conclusion
Coronary embolic phenomena are a heterogeneous group of clinicopathologic 
entities attributable to a variety of etiologic factors. Due to their rarity and the 
tendency to clinically mimic other coronary syndromes, CEPs are often underdiag-
nosed. Timely diagnosis using an elevated index of suspicion in high-risk patients 
is important to improving the associated morbidity and mortality. Scarcity of high 
quality data regarding CEPs necessitates further studies and dedicated consensus 
guidelines. Progress in diagnosis and treatment of CEPs will require concerted 
efforts by clinicians, educators, and researchers.
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